Effect of auricular acupressure and acupoint application on preoperative anxiety of patients undergoing elective surgery

注册号:

Registration number:

ITMCTR1900002757

最近更新日期:

Date of Last Refreshed on:

2019-11-14

注册时间:

Date of Registration:

2019-11-14

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

耳穴埋豆联合穴位贴敷对择期手术患者术前焦虑的影响

Public title:

Effect of auricular acupressure and acupoint application on preoperative anxiety of patients undergoing elective surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

耳穴埋豆联合穴位贴敷对择期手术患者术前焦虑的影响

Scientific title:

Effect of auricular acupressure and acupoint application on preoperative anxiety of patients undergoing elective surgery

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR1900027469 ; ChiMCTR1900002757

申请注册联系人:

周佳

研究负责人:

周佳

Applicant:

Jia Zhou

Study leader:

Jia Zhou

申请注册联系人电话:

Applicant telephone:

+86 15105878708

研究负责人电话:

Study leader's telephone:

+86 15105878708

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

2324328570@qq.com

研究负责人电子邮件:

Study leader's E-mail:

2324328570@qq.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

浙江省温州市锦绣路75号

研究负责人通讯地址:

浙江省温州市锦绣路75号

Applicant address:

75 Jinxiu Road, Wenzhou, Zhejiang, China

Study leader's address:

75 Jinxiu Road, Wenzhou, Zhejiang, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

温州市中西医结合医院

Applicant's institution:

Wenzhou Integrated Traditional Chinese and Western Medicine Hospital

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

N/A

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

温州市中西医结合医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Wenzhou Integrated Traditional Chinese and Western Medicine Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2019/11/5 0:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

周佳

Primary sponsor:

Jia Zhou

研究实施负责(组长)单位地址:

浙江省温州市锦绣路75号

Primary sponsor's address:

75 Jinxiu Road, Wenzhou, Zhejiang, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江省

市(区县):

温州市

Country:

China

Province:

Zhejiang

City:

Wenzhou

单位(医院):

温州市中西医结合医院

具体地址:

锦绣路75号

Institution
hospital:

Wenzhou Integrated Traditional Chinese and Western Medicine Hospital

Address:

75 Jinxiu Road

经费或物资来源:

温州市科技局

Source(s) of funding:

Wenzhou science and technology bureau

研究疾病:

术前焦虑

研究疾病代码:

Target disease:

Preoperative anxiety

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

探讨耳穴埋豆联合穴位贴敷对择期手术患者术前焦虑的影响。

Objectives of Study:

To investigate the effect of auricular acupressure and acupoint application on preoperative anxiety of patients undergoing elective surgery.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1)均为普外科择期手术患者,且入院至手术间隔≥5 d; 2)患者具备基本的沟通理解能力,知晓本研究目的,签署知情同意书; 3)患者年龄25~70岁,性别不限,具备择期手术指征。

Inclusion criteria

1) all patients underwent elective surgery in general surgery, and the interval between admission and surgery was >= 5 days; 2) the patient has basic communication and understanding ability, knows the purpose of this study, and signs the informed consent; 3) the patient was 25~70 years old, regardless of gender, with indications of elective surgery.

排除标准:

1)合并严重心脑血管疾病、肝肾功能不全、恶性肿瘤、造血免疫系统功能障碍等; 2)颅脑损伤、呼吸系统疾病、内分泌疾病或精神心理性疾病者; 3)长期服用精神类药物者; 4)配合研究依从性较差者。

Exclusion criteria:

1) complicated with serious cardiovascular and cerebrovascular diseases, liver and kidney dysfunction, malignant tumor, hematopoietic immune system dysfunction, etc.; 2) craniocerebral injury, respiratory system disease, endocrine disease or mental and psychological disease; 3) long-term use of psychotropic drugs; 4) poor compliance of cooperation research.

研究实施时间:

Study execute time:

From 2019-12-01

To      2020-06-30

征募观察对象时间:

Recruiting time:

From 2019-12-01

To      2020-06-30

干预措施:

Interventions:

组别:

穴位贴敷组

样本量:

40

Group:

Acupoint Application Group

Sample size:

干预措施:

穴位贴敷

干预措施代码:

Intervention:

acupoint application

Intervention code:

组别:

耳穴埋豆组

样本量:

40

Group:

Auricular Acupressure Group

Sample size:

干预措施:

耳穴埋豆

干预措施代码:

Intervention:

auricular acupressure

Intervention code:

组别:

耳穴埋豆联合穴位贴敷组

样本量:

40

Group:

Auricular Acupressure Combined with Acupoint Application Group

Sample size:

干预措施:

耳穴埋豆联合穴位贴敷

干预措施代码:

Intervention:

auricular acupressure combined with acupoint application

Intervention code:

样本总量 Total sample size : 120

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

浙江

市(区县):

温州

Country:

China

Province:

Zhejiang

City:

Wenzhou

单位(医院):

温州市中西医结合医院

单位级别:

三甲

Institution/hospital:

Wenzhou Integrated Traditional Chinese and Western Medicine Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

状态-特质焦虑问卷

指标类型:

主要指标

Outcome:

STAI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

收缩压

指标类型:

主要指标

Outcome:

SBP

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

舒张压

指标类型:

主要指标

Outcome:

DBP

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心率

指标类型:

主要指标

Outcome:

HR

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

唾液

组织:

Sample Name:

Saliva

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

标本中文名:

唾液

组织:

Sample Name:

Saliva

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小
Min age years
最大
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

不知情的研究者根据电脑系统自动生成产生随机

Randomization Procedure (please state who generates the random number sequence and by what method):

Unwitting researchers generate randomness based on automatic generation by computer systems

盲法:

未说明

Blinding:

Not stated

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

临床试验公共平台管理:http://www.medresman.org.cn.

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Clinical trial public platform management http://www.medresman.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

临床试验公共平台管理:http://www.medresman.org/login.aspx

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Clinical trial public platform management http://www.medresman.org/login.aspx

数据管理委员会:

Data Managemen Committee:

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above